ATLAS fair value
ATLAS has no fair value for this stock today.
Profound Medical stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Toronto Stock Exchange · Canada
Prices as of Oct 27, 2026 · CAD
ATLAS has no fair value for this stock today.
47%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Profound Medical a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CA$6.88 and CA$8.76; in 9 out of 10, between CA$5.56 and CA$10.85. Estimated annual volatility is 72%.
ATLAS does not publish a fair value for PRN.TO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks PRN.TO has traded between CA$6.52 and CA$12.40. Today it is 36.5% below that high and 21% above its low.
Its beta is 0.56: it tends to move less than the market.
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.
Want to see everything about Profound Medical?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.
47%: close to a coin flip. In half of the simulated outcomes, PRN.TO ends the month between CA$6.88 and CA$8.76.
Profound Medical's market capitalization is CA$340M. We do not show a P/E because it has no positive earnings to base one on.
ATLAS estimates annual volatility at 72%. In a typical month, half of the outcomes end between CA$6.88 and CA$8.76.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy